Investor Presentaiton

Operating Expenses Selling and Marketing Expenses and as % of Revenue 2.2% (RMB mm) Administrative Expenses and as % of Revenue 2.4% 8.9% (RMB mm) R&D Expenses and as % of Revenue 9.4% 3.1% (RMB mm) Share-based Compensation and as % of Revenue 3.5% 0.7% (RMB mm) 1.5% +11.3% +9.0% +15.9% 128.1 89.0 80.0 350.2 110.5 321.4 +116.4% 25.6 55.4 1H2022 1H2023 1H2022 1H2023 1H2022 1H2023 1H2022 1 H2023 ● Tigermed 7

View entire presentation